Showing results (1441-1450 of 1,483) with videos related to

Sort By:
Pageof 149
JAMA Network Open|November 11, 2022
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation TherapyIrini Youssef, Jennifer Yoon, Nader Mohamed, et al.
International Journal of Radiation Oncology, Biology, Physics|October 3, 2025
Postoperative Human Papilloma Virus Circulating Tumor DNA Guided Adjuvant Therapy for Human Papilloma Virus-Related Oropharyngeal Carcinoma (PATH Study)Linda Chen, Marc Cohen, Vaios Hatzglou, et al.
Oral Oncology|February 17, 2026
Defining response-adapted surgery after neoadjuvant systemic therapy in sinonasal squamous cell carcinomaJennifer R Cracchiolo, Fergal Kavanagh, Michael T Starc, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2023
Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial CancerPeter H O'Donnell, Matthew I Milowsky, Daniel P Petrylak, et al.
Human Mutation|June 27, 2019
Assessing the performance of in silico methods for predicting the pathogenicity of variants in the gene CHEK2, among Hispanic females with breast cancerAlin Voskanian, Panagiotis Katsonis, Olivier Lichtarge, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2022
Hereditary retinoblastoma iPSC model reveals aberrant spliceosome function driving bone malignanciesJian Tu, Zijun Huo, Yao Yu, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|March 19, 2024
Ten-year epidemiology and risk factors of cytomegalovirus infection in hematopoietic stem cell transplantation patients in TaiwanYi-Che Huang, Fei-Yuan Hsiao, Shang-Ting Guan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2024
A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration-Resistant Prostate CancerAna M Aparicio, Rebecca S S Tidwell, Shalini S Yadav, et al.
Cancers|April 3, 2021
High-Grade B-Cell Lymphoma (HGBL) with MYC and BCL2 and/or BCL6 Rearrangements Is Predominantly BCL6-Rearranged and BCL6-Expressing in TaiwanCheng-Chih Tsai, Yung-Cheng Su, Oluwaseun Adebayo Bamodu, et al.
International Journal of Cancer|October 15, 2019
Platinum-based regimens versus cetuximab in definitive chemoradiation for human papillomavirus-unrelated head and neck cancerThomas H Beckham, Christian Barney, Erin Healy, et al.
Pageof 149